25 results
8-K
EX-10.1
AFIB
Acutus Medical Inc
9 Nov 23
Entry into a Material Definitive Agreement
6:41pm
be expected to last for more than three months; (ii) a recall which could reasonably be expected to result in aggregate liability to the Borrower
8-K
EX-10.1
AFIB
Acutus Medical Inc
1 Jul 22
Entry into a Material Definitive Agreement
6:47am
Product, which discontinuance, withdrawal or delay could reasonably be expected to last for more than three months; (ii) a recall which could
8-K
EX-2.1
AFIB
Acutus Medical Inc
27 Apr 22
Acutus Medical Announces Agreements to Fund Strategic Growth Priorities
6:30am
liability to the Seller or any voluntary or involuntary recall of any Seller Products, or similar written correspondence or written notice from the FDA … ) credits or allowances given or made for rejection, recall, return or wastage replacement, or for rebates or retroactive price reductions;
(c) price
8-K
EX-99.2
tzrh02ov0glb n5bmh7j
12 Nov 21
Acutus Medical Reports Third Quarter 2021 Financial Results
5:16pm
424B4
qjl5v0ml2d 19
15 Jul 21
Prospectus supplement with pricing info
4:50pm
DRS
m0mbbxl dhtv4x
27 May 21
Draft registration statement
12:00am
10-K
siod1jj0w4
19 Mar 21
Annual report
12:00am
424B4
o8fykc jo1j7qn
7 Aug 20
Prospectus supplement with pricing info
12:00am
S-1
EX-10.1
iqclcg4k
15 Jul 20
IPO registration
4:53pm
S-1
EX-10.4
uzbog2t
15 Jul 20
IPO registration
4:53pm
S-1
EX-2.1
vvrw cfld87yxg
15 Jul 20
IPO registration
4:53pm
S-1
1jutd3r
15 Jul 20
IPO registration
4:53pm
S-1
EX-10.3
npspy7j48e7m
15 Jul 20
IPO registration
4:53pm
S-1
EX-10.5
mswn1nmk ge8igwx1x
15 Jul 20
IPO registration
4:53pm
DRS/A
EX-10.4
1tbhklu
29 Jun 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.5
wp4w2
29 Jun 20
Draft registration statement (amended)
12:00am